Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Transcutaneous Technologies was a medical technology company specializing in the development of advanced iontophoretic drug delivery systems. The company's proprietary technology enabled the needle-free, controlled delivery of drugs through the skin using low-level electrical currents. Its lead applications focused on local anesthesia and pain management, notably through its integrated, disposable patch systems. In 2005, the company was acquired by Hisamitsu Pharmaceutical, a leader in transdermal patch technology, to enhance its portfolio of drug delivery solutions. The acquisition allowed for the integration of electronic delivery methods into traditional transdermal therapies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Transcutaneous Technologies.